# Jiwon Koh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jiwon-koh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,691 |
| Field | HER2/EGFR in Cancer Research |
| h-index | 23 |
| i10-index | 38 |
| Last Known Institution | Seoul National University |
| OpenAlex ID | https://openalex.org/A5023831858 |
| ORCID iD | 0000-0002-7687-6477 |
| Works | 135 |

## Researcher papers

- [Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor](https://scholariq.org/papers/concomitant-alk-translocation-and-egfr-mutation-in-lung-cancer-a-comparison-of/)
- [PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs](https://scholariq.org/papers/pd-l1-testing-in-gastric-cancer-by-the-combined-positive-score-of-the-22c3/)
- [Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer](https://scholariq.org/papers/immunoscore-encompassing-cd3-and-cd8-t-cell-densities-in-distant-metastasis-is-a/)
- [Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry](https://scholariq.org/papers/expression-of-the-immune-checkpoint-receptors-pd-1-lag3-and-tim3-in-the-immune/)
- [Molecular Testing for Gastrointestinal Cancer](https://scholariq.org/papers/molecular-testing-for-gastrointestinal-cancer/)
- [Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients](https://scholariq.org/papers/clinicopathologic-implications-of-immune-classification-by-pd-l1-expression-and/)
- [BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis](https://scholariq.org/papers/braf-pik3ca-and-her2-oncogenic-alterations-according-to-kras-mutation-status-in/)
- [Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of <i>HAVCR2</i> mutations](https://scholariq.org/papers/genetic-profiles-of-subcutaneous-panniculitis-like-t-cell-lymphoma-and/)
- [Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer](https://scholariq.org/papers/longitudinal-multi-omics-study-of-palbociclib-resistance-in-hr-positive-her2/)
- [Prediction of &lt;i&gt;TP53&lt;/i&gt; mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer](https://scholariq.org/papers/prediction-of-and-lt-i-and-gt-tp53-and-lt-i-and-gt-mutations-by-p53/)
- [Treatment strategies based on the molecular subtypes of transformed small cell lung cancer (t-SCLC)](https://scholariq.org/papers/treatment-strategies-based-on-the-molecular-subtypes-of-transformed-small-cell/)

## Researcher topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Seoul National University](https://scholariq.org/institutions/seoul-national-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.